APA (7th ed.) Citation

Farrell, M., Shahbazi, J., Chambers, M., Byrne, M., Gholami, J., Zahra, E., . . . Degenhardt, L. (2024). 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial. International Journal of Drug Policy, 127, N.PAG. https://doi.org/10.1016/j.drugpo.2024.104390

Chicago Style (17th ed.) Citation

Farrell, Michael, et al. "96-week Retention in Treatment with Extended-release Subcutaneous Buprenorphine Depot Injections Among People with Opioid Dependence: Extended Follow-up After a Single-arm Trial." International Journal of Drug Policy 127 (2024): N.PAG. https://doi.org/10.1016/j.drugpo.2024.104390.

MLA (9th ed.) Citation

Farrell, Michael, et al. "96-week Retention in Treatment with Extended-release Subcutaneous Buprenorphine Depot Injections Among People with Opioid Dependence: Extended Follow-up After a Single-arm Trial." International Journal of Drug Policy, vol. 127, 2024, p. N.PAG, https://doi.org/10.1016/j.drugpo.2024.104390.